S869 TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T-CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY
- Resource Type
- Source
- HemaSphere. 3:389
- Subject
business.industry Cancer research medicine Phases of clinical research Tipifarnib Hematology Open label medicine.disease business Refractory Angioimmunoblastic T-cell Lymphoma Peripheral T-cell lymphoma medicine.drug - Language
- ISSN
- 2572-9241